Category Archives: Health: Addiction

Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.

Health: Addiction

Synergy Billing Corp. Welcomes WellPha Specialty Pharmacy to its Customer Portfolio

Leave a comment


“We are thrilled to welcome WellPha into the Synergy family,” said Jennifer Arms, managing partner for Synergy Billing Corp. “WellPha’s needs are specific, as with many specialty pharmacies. We understand this because each of our customers has touchpoints that require a revenue cycle partner that prioritizes customization while also bringing industry familiarity to the process.” Arms continued, “We believe in this partnership and look forward to seeing it continue to grow in years to come.”

Bernard Fischman, co-owner of WellPha, shared his support for the partnership: “Choosing Synergy Billing Corp was a strategic decision. The complexities of billing for Medicare hemophilia patients require precision and familiarity. Synergy’s experience in this niche and its commitment to tailored solutions assured us they could help us effectively navigate the process. This partnership enhances our operational efficiencies and enables us to extend our services to an even broader patient population.”

Synergy takes pride in tailoring its revenue cycle management services to meet each customer’s unique needs, ensuring that no two service profiles are identical. This high-touch approach has driven the company’s growth in a successful first half of 2023, with Synergy reporting:

  • An 82% increase in revenue over the same period in 2022
  • Earnings grew by 1,021% compared to the same period last year
  • A 36% increase in the number of clients from this time a year ago
  • Fifteen (15) new employees have been onboarded

Synergy Billing Corp. is committed to setting the industry standard for every customer. Visit www.synergybillingcorp.com to learn more, or call us at 412.909.4064.

About Synergy Billing Corp.

Synergy Billing Corp. is a boutique firm that provides revenue cycle and consulting solutions to home infusion and specialty pharmacy healthcare companies. Synergy specializes in assisting with home infusion reimbursement and removing administrative burdens, allowing clients to stay focused on their primary business. The company supports its clients through all phases of the revenue cycle, including benefits verification, pre- and continuing authorizations, billing, collections, and cash posting. Synergy Billing Corp. was founded in 2018 and is headquartered in High Point, N.C. For more information, visit www.SynergyBillingCorp.com or connect with us on LinkedIn or Instagram.

About WellPha Specialty Pharmacy

WellPha Specialty Pharmacy delivers highly customized, home-based infusion and specialty medical treatment services to patients nationwide. The company, founded in 2021 and headquartered in Brooklyn, NY, offers premium pharmaceutical products and leading customer service that elevates the patient, provider, and manufacturer experience. WellPha’s singular mission is to ensure the best treatments for each condition, centered on its promise of care, compassion, and expertise with every interaction. For a complete listing of available therapeutics and disease management services or to learn more about WellPha Specialty Pharmacy, visit www.WellPha.com.

Media Contact

Victoria Seremeta, Synergy Billing Corp., 1 5162861950, [email protected], www.synergybillingcorp.com

SOURCE Synergy Billing Corp.



Health: Addiction

Dr. Vijay Ivaturi Announced as New Chief Executive Officer at PumasAI

Leave a comment


During Dr. Gobburu’s tenure as CEO, the company has achieved significant milestones and has propelled PumasAI to new heights, achieving robust financial health and groundbreaking advancements in our field. From a company that initially had 3 members, PumasAI has come a long way to comprise of more than 40 team members, a robust organizational structure, sound financial health, an unparalleled line of products, and model-informed drug development consulting services.

As Dr. Gobburu takes on the role of Chairman of the Board, he will continue to contribute his invaluable insights and guidance to the strategic direction of the company. In this capacity, he will work closely with the Board of Directors to ensure a seamless transition and provide ongoing support to the new CEO.

Dr. Gobburu commented on the transition, saying, “The unwavering support and strength exhibited by the Executive Leadership Team have instilled in me the confidence to hand over the reins of the day-to-day running of the company to Dr. Ivaturi, whose exceptional leadership skills reassure me that PumasAI is in capable hands for the next chapter. While stepping back, I eagerly anticipate remaining engaged in contributing to the company’s strategic direction.”

Dr. Ivaturi expressed gratitude for the opportunity to lead PumasAI and is eager to contribute to the continued success and growth of the company. He said, “As I step into the role of CEO at PumasAI, I am profoundly thankful for the robust platform established by Dr. Gobburu. The groundwork laid in the past four years is a testament to visionary leadership and collaborative effort. I am honored to inherit this legacy and am fully committed to driving our mission forward with a focused and winning strategy. We stand on the cusp of new possibilities, and I am eager to lead our talented team in exploring these opportunities. Together, we will continue to innovate and excel, ensuring that PumasAI remains at the forefront of our industry. Here’s to a future filled with growth and groundbreaking achievements.”

For additional information, visit www.pumasai.com

Media Contact

Don F. McLean, McLean Media, 1 7347164182, mclean.donald@gmail.com

SOURCE PumasAI

Health: Addiction

Osmind Announces Virtual 2023 Breakthrough Mental Health Treatment Forum to Advance Mental Health Research, Treatment, and Community

Leave a comment


Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation’s foremost mental health clinicians driving breakthrough medicine

SAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ — Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness.

“The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind,” said Lucia Huang, co-founder and CEO of Osmind. “This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations.”

The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously. Register here to gain immediate access to day one content.

Session Overview

The Current and Future State of Mental Health and Research

Available starting at 6 a.m. PT/9 a.m. ET, Tuesday, December 5, 2023

This session delivers a deep dive into the evolving landscape of psychiatry, including the future applications of precision psychiatry, big data, patient-centered care, and novel treatment modalities such as psychedelics, TMS, and ketamine. Speakers include:

  • Tobias Marton, MD – Chief Medical Officer at Mindful Health Solutions
  • Christy Duan, MD – Clinical Assistant Professor, NYU Grossman School of Medicine & private practice psychiatrist
  • David Feifel, MD, PhD – Founder and President at Kadima Neuropsychiatry Institute

Starting a Successful Mental Health Practice

Available starting at 6 a.m. PT/9 a.m. ET, Tuesday, December 6, 2023

This session is designed to empower more clinicians to pioneer and expand private practices, helping improve access to care for patients. Explore best practices for running a business that combats professional burnout and carves out a unique niche that resonates with your values and the needs of your patients. Speakers include:

  • Kristin Budde, MD – Co-Founder of Cerebella and Psychiatrist at the Ellenhorn PACT program
  • Erick Sheftic, MD – Co-Founder at Accelerated Psychiatry
  • Raghu Appasssani, MD – Integrative Psychiatrist & Psychotherapist at Appasani MD

The Power of Community

Available starting at 6 a.m. PT/9 a.m. ET, Thursday, December 7, 2023

Professional community is a key component for practitioners and practices that deliver mental health treatments. This session delivers insights into professional growth and supporting patient care through community engagement, in part, building off of the Osmind Community Advisory Board and Osmind Practice Community made up of 800+ members. Speakers include:

  • Awais Aftab, MD – Clinical Assistant Professor of Psychiatry, Case Western Reserve University
  • Charles Miller, CRNA – Founder and CMO at Scenic City Neurotherapy
  • Andrew Penn, MS, PMHNP – Clinical Professor at UC San Francisco, School of Nursing
  • Michael Banov, MD – Medical Director of Psych Atlanta

“The community is a valuable resource for people interested in private practice, those with questions about the logistics of it, and those seeking guidance on applying existing research evidence to their clinical practice,” said Dr. Aftab. “It helps them translate available scientific information and protocols into actionable steps they can implement in the real world.”

Osmind is used by hundreds of leading mental health practices across the U.S. It is the most comprehensive EHR platform designed for psychiatry, focused on advancing evidence-based mental health treatments to increase access to care. For more information about the Osmind platform for mental health clinicians, please visit www.osmind.org.

About Osmind

Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists to advance new evidence-generating medicine that helps people living with moderate to severe mental health conditions. For more information, please visit www.osmind.org.

Media Contact

Sabas Rodriguez, Osmind, 1 (650) 800-5440, [email protected], osmind.org

SOURCE Osmind

Health: Addiction

Ideal Option Opens Largest Addiction Medicine Center in Yakima

Leave a comment


The new, high-capacity clinic will vastly increase the number of individuals in active treatment and recovery from substance use disorder.

YAKIMA, Wash., Dec. 4, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, has opened a new addiction medicine center in Yakima.

The new center merges their two existing Yakima clinics at 11th Ave and River Rd into one location at 602 N 39th Ave. Located in the same building as Yakima County Medical Society, the center is staffed with three addiction medicine providers and five medical assistants and patients receive support from a peer outreach specialist. With capacity to see up to 75 patients per day, the clinic is the largest of its kind in Yakima.

A trusted, low-barrier provider in Yakima for over 10 years, Ideal Option carries no waitlists, accepts Medicaid and serves all patients with respect and dignity. Ideal Option providers are experts in treating high-risk patients who need specialized protocols for complex drug combinations or health conditions such as pregnancy and chronic disease.

Ideal Option data support the effectiveness of medication-assisted treatment for opioid use disorder. Among Washington state patients who continued treatment with Ideal Option throughout 2022, urine drug testing revealed a remarkable 98% reduction in fentanyl use and a 94% reduction in total opioid use.

With the recent expansion of its in-house laboratory capabilities, Ideal Option is now able to detect dozens of fentanyl analogs, nitazines, novel psychoactive substances, and cutting agents such as xylazine and lidocaine – information used to guide personalized treatment plans.

According to data from the Yakima County Coroner’s Office, 98 residents died of a drug overdose last year, a 34% increase from the 73 deaths reported in 2020. Of the overdose deaths that occurred in 2020 and 2021, more than 60% involved opioids, with fentanyl being the most common opioid involved in those deaths.

“Yakima has been hit particularly hard by the street drug epidemic, so a high-capacity centralized, low-barrier resource like this is desperately needed,” said Tyler Vermillion, Ideal Option community outreach coordinator for Eastern Washington. “We hope this beautiful new center will help to normalize treatment and encourage more people suffering from substance use disorder in Yakima County to begin their recovery and reclaim their lives.”

The new treatment center in Yakima is open Monday – Thursday, 7:00 a.m. – 6 p.m. at 602 N 39th Ave, Ste. 200.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Ideal Option’s offices on 11th Ave and River Rd have now closed.

Patients can make an appointment by calling 1.877.522.1275 or visiting‥www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 75,000 patients through a network of 89 office-based medication-assisted treatment (MAT) clinics across 9 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Media Contact

Olivia Roe, Ideal Option, 1 9199466644, [email protected], www.idealoption.com

Twitter, Facebook, LinkedIn

SOURCE Ideal Option



Health: Addiction

Asheville Arthritis & Osteoporosis Center Partners with House Rx to Enhance Patient Care Through Medically Integrated Dispensing

Leave a comment


Asheville Arthritis will lean on House Rx’s specialized technology and services support from a team of pharmacists and pharmacy technicians to manage the dispensing process internally instead of relying on external specialty pharmacies. With third-party specialty pharmacies, patients with complex or chronic illnesses often face delays in getting the medications they need. Further, missed doses can worsen pain, lead to a flare, potentially cause disease progression, leading to high costs for the patient, and the healthcare system. MID has been shown to help patients and their care teams manage side effects, monitor the condition, and quickly make adjustments that improve outcomes and lower costs.

“With the increasing number of patient-administered therapies used to treat autoimmune diseases, we believe medically integrated dispensing is essential to the future of rheumatology care,” said Dr. Ellison Smith, at Asheville Arthritis & Osteoporosis Center. “Our partnership with House Rx will not only help us address common patient delays and hurdles with specialty medication, but also ensure our providers can continue to prescribe and support our patients in having access to the most innovative treatments.”

“We’re proud to be able to support the Asheville Arthritis team in adopting medically integrated dispensing and giving their care teams a way to stay closer to their patient population,” said Alerie Stiles, Senior Vice President of Commercial Growth at House Rx. “They join other forward-thinking rheumatology practices across the country who have recognized the necessity of adopting this care model to continue delivering high-quality, high-value care.”

House Rx’s network now includes over 400 providers who are already dispensing, or are in the process of being set up to dispense, specialty medications directly to patients via the House Rx platform.

About House Rx

House Rx is a healthcare technology and services company focused on making specialty medication more accessible and affordable. The company partners with specialty physicians across the country to enable clinics to adopt a medically integrated approach to pharmacy care known as “medically integrated dispensing.” By bringing medical and pharmacy care together under one roof, specialty clinics are able to better serve patients, lower the cost of care, and create a better experience for patients and their caregivers. Learn more at www.houserx.com.

About Asheville Arthritis & Osteoporosis Center

Asheville Arthritis & Osteoporosis Center is a full-service rheumatology practice caring for adults and children with arthritis, osteoporosis, and systemic autoimmune diseases. With 8 physicians and 1 advanced practice provider on staff, the mission of the Asheville Arthritis & Osteoporosis Center team is to expertly care for persons with rheumatologic disease, with compassion, efficiency, innovation, respect, and integrity.

Media Contact

Allison Blake, House Rx, 1 4157070117, [email protected], https://www.houserx.com/ 

SOURCE House Rx

Health: Addiction

Digital Strategies to Accelerate Modern Biopharmaceutical Process Development, Upcoming Webinar Hosted by Xtalks

Leave a comment


In this session, the attendees will learn key digital strategies to improve process design for cutting-edge therapies, plan better experiments, unify process data and simplify technology transfer. The featured speakers will cover digital strategies for cell line development, upstream and downstream processing and analytical operations.

Join this webinar to gain insights into implementing strategies in technology transfer and biopharmaceutical process development to drive innovation in modern drug modalities.

Join experts from Benchling, Areef Jetha, Market Strategy Lead — Development; and Justin De La Cruz, Solutions Consultant, for the live webinar on Wednesday, December 6, 2023, at 12pm EST (9am PST).

For more information, or to register for this event, visit Digital Strategies to Accelerate Modern Biopharmaceutical Process Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health: Addiction

Shriners Children’s Earns a Four-Star Rating From Charity Navigator

Leave a comment


Since opening its first hospital in 1922, Shriners Children’s has made it their mission to improve the lives of children, regardless of the families’ ability to pay or insurance status. Over the last century, Shriners Children’s has treated more than 1.5 million children from more than 170 countries. Today, their locations in the United States, Canada and Mexico, along with outreach clinics held all over the world, provide innovative care for children with a range of orthopedic issues, burn injuries, craniofacial conditions, spine conditions, spinal cord injuries, colorectal and gastrointestinal conditions, and sports medicine.

“We are delighted to provide Shriners Children’s with third-party accreditation that validates their operational excellence,” said Michael Thatcher, President and CEO of Charity Navigator. “The Four-Star Rating is the highest possible rating an organization can achieve. We are eager to see the good work that Shriners Children’s is able to accomplish in the years ahead.”

Charity Navigator analyzes nonprofit performance based on four key indicators, referred to as beacons. Currently, nonprofits can earn scores for the Impact & Results, Accountability & Finance, Culture & Community, and Leadership & Adaptability beacons. Two objectives drive their approach to rating charities: helping donors and celebrating the work of charities.

“We are proud to receive another Four-Star rating from Charity Navigator,” said Stuart Sullivan, Chief Philanthropy Officer for Shriners Children’s. “This distinction is further validation that our supporters can trust Shriners Children’s commitment to good governance and financial health, and feel empowered knowing they are making an impactful difference in the lives of children around the world.”

Shriners Children’s rating and other information about charitable giving are available free of charge on charitynavigator.org.

About Shriners Children’s

Shriners Children’s is changing lives every day by providing innovative pediatric specialty care, conducting research to improve the quality of lives, and of care, and offering outstanding educational programs for medical professionals. Our locations in the United States, Canada and Mexico provide care for children with orthopedic conditions, burn injuries, spinal cord injuries and other spine disorders, rehabilitation, sports injuries and craniofacial conditions. All care and services are provided regardless of the families’ ability to pay or insurance status. Shriners Children’s has treated more than 1.5 million children since its founding in 1922.

For more information on the care provided by Shriners Children’s, go to shrinerschildrens.org.

Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law.

Media Contact

Ashley Ozols-Thomas, Shriners Children’s, 1 813-499-4273, [email protected], shrinerschildrens.org

SOURCE Shriners Children’s

Health: Addiction

Codoxo and NHCAA Institute Co-Sponsor Generative AI Webinar

Leave a comment


“Payment integrity continues to be a challenge for the healthcare industry, and generative AI is proving to be a game-changer with its ability to analyze large volumes of data and quickly provide insights that help organizations ensure accuracy and detect and prevent errors, fraud and abuse,” stated Ahmed. “Codoxo is at the forefront of using generative AI to revolutionize payment integrity, and we look forward to sharing the latest innovations in the space and generating enthusiasm and adoption among our participants.”

Codoxo’s proprietary Forensic AI Engine and Unified Cost Containment Platform is disrupting the cost containment and payment integrity industry by implementing the most innovative and effective AI available to reduce fraud, waste and abuse and ensure payment integrity for health payers, agencies and PBMs. Codoxo is a member of the NHCAA.

Registration for the one-hour webinar is available here.

About Codoxo
With a mission to make healthcare more affordable and effective for everyone, Codoxo is the premier provider of artificial intelligence-driven solutions and services that help healthcare companies and agencies proactively detect and reduce risks from fraud, waste, and abuse and ensure payment integrity. The Codoxo Unified Cost Containment Platform helps clients manage costs across network management, clinical care, provider coding and billing, payment integrity, and special investigation units. Our software-as-a-service applications are built on our proven Forensic AI Engine, which uses patented AI-based technology to identify problems and suspicious behavior far faster and earlier than traditional techniques. Codoxo is a Fierce Healthcare Innovation Award winner and has been recognized by the Inc. 5000 list of fastest growing companies in America. Our solutions are HIPAA-compliant and operate in a HITRUST-certified environment. For additional information, visit Codoxo.

Media Contact

Ronda Duncan, Codoxo, 8472549782, [email protected], https://www.codoxo.com

SOURCE Codoxo

Health: Addiction

Kyowa Hakko Educates the Educators on Cognizin® Citicoline and brain health supplements during a unique event in New York City

Leave a comment


Trail-blazing women of science, education and influence empowered dietitians and nutritionists with crucial facts on science, branded ingredients, dietary supplements, regulations, and market trends.

NEW YORK, Nov. 17, 2023 /PRNewswire-PRWeb/ — Leading international health ingredient manufacturer Kyowa Hakko U.S.A., Inc. celebrated a first-of-its-kind event in New York City on November 8th, embracing the company’s vision of improving people’s health while addressing the increasing interest in brain health supplements.

With consumer demand for brain health supplements on the rise, the Neuro Navigators event was a meeting of the minds where experts and authorities of science, education and influence debunked some of the myths surrounding dietary supplements and presented facts backed by science and regulations to an engaged audience of dietitians and nutritionists.

Karen E. Todd, RD, CSCS, EP-C, CISSN and Vice President Global Brand Marketing for Kyowa Hakko, U.S.A., Inc., led the conversation with opening remarks that covered the overall state of the industry where 74 percent of U.S. adults have reported taking supplements, according to the 2023 CRN Consumer Survey in Dietary Supplement.

Along with keynote speaker, nationally recognized Keri Glassman, MS, RD, CDN, panelists and guest speakers at the event included Danielle Citrolo, PharmD and VP Scientific and Regulatory Affairs, Kyowa Hakko, U.S.A., Inc.; Ashley Jordan Ferira, Ph.D., RDN and Vice President of Scientific Affairs at mindbodygreen; Hannah Margaret Allen, panel, Q&A moderator and head of content at mindbodygreen; Crystal Webber, MS, RD and & Chief Innovation Officer of FIG – Formulation Innovations Group, Diana Morgan, MS, CISSN and Vice President Global Regulatory & Government Affairs for Nutrabolt® and Amy Gorin, MS, RDN and CEO of Master the Media.

Attendees heard exciting discussions about choosing the right supplements as one of the tools at people’s disposal to achieve optimal brain health. They also learned that although there are different things to look for in a label, highlighting these three items: branded ingredients, third-party certifications and regulated claims are key when searching for trustworthy supplements. There was great interest in the discussions on the power of research to validate the studies behind supplements. Kyowa Hakko’s branded ingredient Cognizin® Citicoline is a case in point due to its over 30 clinical studies.

Discussions about the regulation of the supplement industry, which the U.S. Food & Drug Administration (FDA) oversees under its subcategory of food, received a great reception among attendees due in part to the recent surge in news articles discussing the role of dietitians and experts endorsing products – transparency was the key take-away.

Gummies and guiding consumers on how to choose better ones was the talk of the day as one of the market trends that are here to stay. Finally, the main goal of the event, educating healthcare professionals on assessing and identifying supplements with the best-quality ingredients and effective doses while ensuring they have the right tools to guide their clients responsibly, was achieved.

Kyowa Hakko U.S.A. President, Gerard Adams, in a post event interview indicated the Kirin Group’s (parent company of Kyowa Hakko) values were exemplified during the event with a display of passion, integrity and diversity. “From the participation and enthusiasm of both the livestream and in-person audience to the transparency, with which we pride ourselves on as the trusted supplier and partner for our customers and consumers, combined with the diversity of these women of science-focused event, supported everything that we passionately believe in.”

To learn more about Cognizin® Citicoline, please visit: https://cognizin.com. For interviews with any of the speakers, contact Giselle Chollett at [email protected] or 917.386.7116.

About Cognizin® Citicoline:
Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. For more information on Cognizin®, visit Cognizin.com.

About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

Media Contact

Maria Stanieich, Kyowa Hakko USA, 5514829968, [email protected], https://cognizin.com/

SOURCE Kyowa Hakko USA

Health: Addiction

David Shulkin, Former US Secretary of Veterans Affairs, Joins Kontakt.io’s Healthcare Advisory Board

Leave a comment


In addition to his government service, Dr. Shulkin is a renowned healthcare executive who has held leadership positions at several prominent hospitals and health systems. Notably, he served as the Chief Executive Officer of Beth Israel in New York and Morristown Medical Center in New Jersey, where he drove strategic initiatives and improved patient outcomes.

“Dr. Shulkin’s deep understanding of healthcare systems, both in government and the private sector, is invaluable,” commented Philipp von Gilsa, CEO of Kontakt.io. “With his guidance, we will continue to trailblaze in our relentless effort to digitally transform health systems and help them optimize operations and transform experiences.”

“I follow health technology closely, and I have found Kontakt.io’s solutions highly differentiated and compelling,” stated Dr. Shulkin. “Providers today are prioritizing improved efficiencies and workforce issues. Kontakt.io offers best-in-class solutions for these priorities.”

For more information about Kontakt.io’s healthcare solutions, please visit kontakt.io/solutions-healthcare.

About Kontakt.io

Kontakt.io is the leader in Inpatient Journey Analytics. By understanding how patients and equipment move through the care delivery process, we uncover waste, optimize workflows, streamline capacity, and help your staff and patients feel seen and valued. Using AI, IoT, and RTLS, we enable responsive health systems that anticipate and adapt to constantly changing operational and human needs. Since 2013, Kontakt.io has provided solutions to +32,000 end users, delivered via +1,200 partners, and deployed +4 million IoT devices in the field.

Media Contact

Olivia Wang, Kontakt.io, 1 6088868698, [email protected], Kontakt.io

SOURCE Kontakt.io